FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource CodeSystem/FHIR Server from package hl7.terminology#current (32 ms)

Package hl7.terminology
Type CodeSystem
Id Id
FHIR Version R5
Source http://terminology.hl7.org/https://build.fhir.org/ig/HL7/UTG/CodeSystem-v3-substanceAdminSubstitution.html
Url http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution
Version 3.0.0
Status active
Date 2019-03-20
Name SubstanceAdminSubstitution
Title Substance Admin Substitution
Experimental False
Realm uv
Authority hl7
Description Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.
Copyright This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Content complete

Resources that use this resource

ValueSet
http://hl7.it/fhir/dossier-pharma/ValueSet/substitution-it-dossierPharma Regole di sostituzione
http://terminology.ehdsi.eu/ValueSet/eHDSISubstitutionCode eHDSI Substitution Code
http://fhir.ch/ig/ch-term/ValueSet/ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode
v3-ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode
v3-SubstanceAdminGenericSubstitution SubstanceAdminGenericSubstitution
http://fhir.ch/ig/ch-emed-epr/ValueSet/ch-emed-epr-substance-admin-substitution-code Substance Administration Substitution Codes
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsisubstitutioncode Cyprus EHR Value Set: eHDSI Substitution Code

Resources that this resource uses

No resources found



Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem v3-substanceAdminSubstitution

Language: en

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
SpecializesSpecializesCodingThe child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.
GeneralizesGeneralizesCodingInverse of Specializes. Only included as a derived relationship.
internalIdinternalIdhttp://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-idcodeThe internal identifier for the concept in the HL7 Access database repository.
Not SelectablenotSelectablehttp://hl7.org/fhir/concept-properties#notSelectablebooleanIndicates that the code is abstract - only intended to be used as a selector for other concepts
Statusstatushttp://hl7.org/fhir/concept-properties#statuscodeDesignation of a concept's state. Normally is not populated unless the state is retired.

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution defines the following codes in a Is-A hierarchy:

LvlCodeDisplayDefinitioninternalIdNot SelectableStatus
1_ActSubstanceAdminSubstitutionCode ActSubstanceAdminSubstitutionCode

Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

21284trueactive
2  E equivalent

Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

23107active
3    EC equivalent composition

Substitution occurred or is permitted with another product that is a:

  • pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
  • pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration

Examples:

  • Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
  • Pharmaceutical equivalent: Lisonpril for Zestril
23108active
4      BC brand composition

Substitution occurred or is permitted between equivalent Brands but not Generics

Examples:

  • Zestril for Prinivil
  • Coumadin for Jantoven
23109active
4      G generic composition

Substitution occurred or is permitted between equivalent Generics but not Brands

Examples:

  • Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
16623active
3    TE therapeutic alternative

Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.

Examples:

  • ranitidine for Tagamet
16624active
4      TB therapeutic brand

Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics

Examples:

  • Zantac for Tagamet
23105active
4      TG therapeutic generic

Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands

Examples:

  • Ranitidine for cimetidine
23106active
2  F formulary

This substitution was performed or is permitted based on formulary guidelines.

16625active
2  N none

No substitution occurred or is permitted.

16622active

Source

{
  "resourceType" : "CodeSystem",
  "id" : "v3-substanceAdminSubstitution",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem v3-substanceAdminSubstitution</b></p><a name=\"v3-substanceAdminSubstitution\"> </a><a name=\"hcv3-substanceAdminSubstitution\"> </a><a name=\"v3-substanceAdminSubstitution-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: en</p></div><p><b>Properties</b></p><p><b>This code system defines the following properties for its concepts</b></p><table class=\"grid\"><tr><td><b>Name</b></td><td><b>Code</b></td><td><b>URI</b></td><td><b>Type</b></td><td><b>Description</b></td></tr><tr><td>Specializes</td><td>Specializes</td><td/><td>Coding</td><td>The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.</td></tr><tr><td>Generalizes</td><td>Generalizes</td><td/><td>Coding</td><td>Inverse of Specializes. Only included as a derived relationship.</td></tr><tr><td>internalId</td><td>internalId</td><td>http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id</td><td>code</td><td>The internal identifier for the concept in the HL7 Access database repository.</td></tr><tr><td>Not Selectable</td><td>notSelectable</td><td>http://hl7.org/fhir/concept-properties#notSelectable</td><td>boolean</td><td>Indicates that the code is abstract - only intended to be used as a selector for other concepts</td></tr><tr><td>Status</td><td>status</td><td>http://hl7.org/fhir/concept-properties#status</td><td>code</td><td>Designation of a concept's state. Normally is not populated unless the state is retired.</td></tr></table><p><b>Concepts</b></p><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution</code> defines the following codes in a Is-A hierarchy:</p><table class=\"codes\"><tr><td><b>Lvl</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td><td><b>internalId</b></td><td><b>Not Selectable</b></td><td><b>Status</b></td></tr><tr><td>1</td><td style=\"white-space:nowrap\">_ActSubstanceAdminSubstitutionCode<a name=\"v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode\"> </a></td><td>ActSubstanceAdminSubstitutionCode</td><td><div><p>Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</p>\n</div></td><td>21284</td><td>true</td><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��E<a name=\"v3-substanceAdminSubstitution-E\"> </a></td><td>equivalent</td><td><div><p>Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</p>\n</div></td><td>23107</td><td/><td>active</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">����EC<a name=\"v3-substanceAdminSubstitution-EC\"> </a></td><td>equivalent composition</td><td><div><p>Substitution occurred or is permitted with another product that is a:</p>\n<ul>\n<li>pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester</li>\n<li>pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration</li>\n</ul>\n<p><em>Examples:</em></p>\n<ul>\n<li><em>Pharmaceutical alternative:</em> Erythromycin Ethylsuccinate for Erythromycin Stearate</li>\n<li><em>Pharmaceutical equivalent:</em> Lisonpril for Zestril</li>\n</ul>\n</div></td><td>23108</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">������BC<a name=\"v3-substanceAdminSubstitution-BC\"> </a></td><td>brand composition</td><td><div><p>Substitution occurred or is permitted between equivalent Brands but not Generics</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>Zestril for Prinivil</li>\n<li>Coumadin for Jantoven</li>\n</ul>\n</div></td><td>23109</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">������G<a name=\"v3-substanceAdminSubstitution-G\"> </a></td><td>generic composition</td><td><div><p>Substitution occurred or is permitted between equivalent Generics but not Brands</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</li>\n</ul>\n</div></td><td>16623</td><td/><td>active</td></tr><tr><td>3</td><td style=\"white-space:nowrap\">����TE<a name=\"v3-substanceAdminSubstitution-TE\"> </a></td><td>therapeutic alternative</td><td><div><p>Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.</p>\n<p><em>Examples:</em></p>\n<ul>\n<li>ranitidine for Tagamet</li>\n</ul>\n</div></td><td>16624</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">������TB<a name=\"v3-substanceAdminSubstitution-TB\"> </a></td><td>therapeutic brand</td><td><div><p>Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics</p>\n<blockquote>\n</blockquote>\n<p><em>Examples:</em></p>\n<ul>\n<li>Zantac for Tagamet</li>\n</ul>\n</div></td><td>23105</td><td/><td>active</td></tr><tr><td>4</td><td style=\"white-space:nowrap\">������TG<a name=\"v3-substanceAdminSubstitution-TG\"> </a></td><td>therapeutic generic</td><td><div><p>Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands</p>\n<blockquote>\n</blockquote>\n<p><em>Examples:</em></p>\n<ul>\n<li>Ranitidine for cimetidine</li>\n</ul>\n</div></td><td>23106</td><td/><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��F<a name=\"v3-substanceAdminSubstitution-F\"> </a></td><td>formulary</td><td><div><p>This substitution was performed or is permitted based on formulary guidelines.</p>\n</div></td><td>16625</td><td/><td>active</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">��N<a name=\"v3-substanceAdminSubstitution-N\"> </a></td><td>none</td><td><div><p>No substitution occurred or is permitted.</p>\n</div></td><td>16622</td><td/><td>active</td></tr></table></div>"
  },
  "url" : "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.5.1070"
    }
  ],
  "version" : "3.0.0",
  "name" : "SubstanceAdminSubstitution",
  "title" : "Substance Admin Substitution",
  "status" : "active",
  "experimental" : false,
  "date" : "2019-03-20",
  "publisher" : "Health Level Seven International",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://hl7.org"
        },
        {
          "system" : "email",
          "value" : "hq@HL7.org"
        }
      ]
    }
  ],
  "description" : "Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.",
  "copyright" : "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "caseSensitive" : true,
  "hierarchyMeaning" : "is-a",
  "content" : "complete",
  "property" : [
    {
      "extension" : [
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry",
          "valueCode" : "antisymmetric"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity",
          "valueCode" : "transitive"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity",
          "valueCode" : "irreflexive"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable",
          "valueBoolean" : true
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind",
          "valueCode" : "Specializes"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName",
          "valueString" : "Generalizes"
        }
      ],
      "code" : "Specializes",
      "description" : "The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.",
      "type" : "Coding"
    },
    {
      "extension" : [
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry",
          "valueCode" : "antisymmetric"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity",
          "valueCode" : "transitive"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity",
          "valueCode" : "irreflexive"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable",
          "valueBoolean" : true
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind",
          "valueCode" : "Generalizes"
        },
        {
          "url" : "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName",
          "valueString" : "Specializes"
        }
      ],
      "code" : "Generalizes",
      "description" : "Inverse of Specializes. Only included as a derived relationship.",
      "type" : "Coding"
    },
    {
      "code" : "internalId",
      "uri" : "http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id",
      "description" : "The internal identifier for the concept in the HL7 Access database repository.",
      "type" : "code"
    },
    {
      "code" : "notSelectable",
      "uri" : "http://hl7.org/fhir/concept-properties#notSelectable",
      "description" : "Indicates that the code is abstract - only intended to be used as a selector for other concepts",
      "type" : "boolean"
    },
    {
      "code" : "status",
      "uri" : "http://hl7.org/fhir/concept-properties#status",
      "description" : "Designation of a concept's state. Normally is not populated unless the state is retired.",
      "type" : "code"
    }
  ],
  "concept" : [
    {
      "code" : "_ActSubstanceAdminSubstitutionCode",
      "display" : "ActSubstanceAdminSubstitutionCode",
      "definition" : "Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.",
      "property" : [
        {
          "code" : "notSelectable",
          "valueBoolean" : true
        },
        {
          "code" : "status",
          "valueCode" : "active"
        },
        {
          "code" : "internalId",
          "valueCode" : "21284"
        }
      ],
      "concept" : [
        {
          "code" : "E",
          "display" : "equivalent",
          "definition" : "Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.",
          "property" : [
            {
              "code" : "status",
              "valueCode" : "active"
            },
            {
              "code" : "internalId",
              "valueCode" : "23107"
            }
          ],
          "concept" : [
            {
              "code" : "EC",
              "display" : "equivalent composition",
              "definition" : "Substitution occurred or is permitted with another product that is a:\r\n\r\n * pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\r\n * pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\r\n\r\n*Examples:* \r\n\r\n * *Pharmaceutical alternative:* Erythromycin Ethylsuccinate for Erythromycin Stearate\r\n * *Pharmaceutical equivalent:* Lisonpril for Zestril",
              "property" : [
                {
                  "code" : "status",
                  "valueCode" : "active"
                },
                {
                  "code" : "internalId",
                  "valueCode" : "23108"
                }
              ],
              "concept" : [
                {
                  "code" : "BC",
                  "display" : "brand composition",
                  "definition" : "Substitution occurred or is permitted between equivalent Brands but not Generics\r\n\r\n*Examples:* \r\n\r\n * Zestril for Prinivil\r\n * Coumadin for Jantoven",
                  "property" : [
                    {
                      "code" : "status",
                      "valueCode" : "active"
                    },
                    {
                      "code" : "internalId",
                      "valueCode" : "23109"
                    }
                  ]
                },
                {
                  "code" : "G",
                  "display" : "generic composition",
                  "definition" : "Substitution occurred or is permitted between equivalent Generics but not Brands\r\n\r\n*Examples:* \r\n\r\n * Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)",
                  "property" : [
                    {
                      "code" : "status",
                      "valueCode" : "active"
                    },
                    {
                      "code" : "internalId",
                      "valueCode" : "16623"
                    }
                  ]
                }
              ]
            },
            {
              "code" : "TE",
              "display" : "therapeutic alternative",
              "definition" : "Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.\r\n\r\n*Examples:* \r\n\r\n * ranitidine for Tagamet",
              "property" : [
                {
                  "code" : "status",
                  "valueCode" : "active"
                },
                {
                  "code" : "internalId",
                  "valueCode" : "16624"
                }
              ],
              "concept" : [
                {
                  "code" : "TB",
                  "display" : "therapeutic brand",
                  "definition" : "Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics\r\n\r\n>\r\n\r\n*Examples:* \r\n\r\n * Zantac for Tagamet",
                  "property" : [
                    {
                      "code" : "status",
                      "valueCode" : "active"
                    },
                    {
                      "code" : "internalId",
                      "valueCode" : "23105"
                    }
                  ]
                },
                {
                  "code" : "TG",
                  "display" : "therapeutic generic",
                  "definition" : "Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands\r\n\r\n>\r\n\r\n*Examples:* \r\n\r\n * Ranitidine for cimetidine",
                  "property" : [
                    {
                      "code" : "status",
                      "valueCode" : "active"
                    },
                    {
                      "code" : "internalId",
                      "valueCode" : "23106"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "code" : "F",
          "display" : "formulary",
          "definition" : "This substitution was performed or is permitted based on formulary guidelines.",
          "property" : [
            {
              "code" : "status",
              "valueCode" : "active"
            },
            {
              "code" : "internalId",
              "valueCode" : "16625"
            }
          ]
        },
        {
          "code" : "N",
          "display" : "none",
          "definition" : "No substitution occurred or is permitted.",
          "property" : [
            {
              "code" : "status",
              "valueCode" : "active"
            },
            {
              "code" : "internalId",
              "valueCode" : "16622"
            }
          ]
        }
      ]
    }
  ]
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.